December 3, 2018
InSysBio launches Youtube channel to share webcasts of talks at conferences and webinars, video tutorials for QSP platforms and other materials related to InSysBio approach and models. Recently uploaded videos are Oleg Demin’s talk “Application of mathematical modeling in drug research and development” and Oleg Demin Jr’s talk “Application of QSP modeling in immuno-oncology” at BiotechClub 2018 conference.
About InSysBio
InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative approach has already become a part of the drug development process implemented by our strategic partners: nowadays there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. The company has published multiple scientific studies in various therapeutic areas. InSysBio team is developing software and tools for QSP and continuously improves methods for biological modeling. For more information about InSysBio, its solutions and services, visit insysbio.com.
| ← | April 2018 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
| ||||||
|
2
|
3
|
4
|
5
1.
05 Apr 2018 15:33
XXV Russian National Congress “Man and Drug”
InSysBio today announced their participation at XXV Russian National Congress “Man and Drug”, to be held in Moscow, Russia, on April 9-12, 2018.
|
6
|
7
|
8
|
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
|
23
|
24
|
25
|
26
1.
26 Apr 2018 15:33
InSysBio, LLC Announces Extension of Collaboration with GSK on Quantitative Systems Pharmacology Modeling in Asthma
InSysBio LLC (www.insysbio.com) – pioneer in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development – announced today further collaboration with GSK - one of the world's leading research-based pharmaceutical and healthcare companies - to expand the previously developed QSP model of asthma.
|
27
|
28
|
29
|
|
30
| ||||||
Thank you for your message! We will get back to you shortly.
